143 related articles for article (PubMed ID: 36076593)
21. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.
Fathers C; Drayton RM; Solovieva S; Bryant HE
Cell Cycle; 2012 Mar; 11(5):990-7. PubMed ID: 22333589
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of the poly(ADP-ribosyl)ation enzymes in uveal melanoma and regulation of PARG gene expression by the transcription factor ERM.
Molloy-Simard V; St-Laurent JF; Vigneault F; Gaudreault M; Dargis N; Guérin MC; Leclerc S; Morcos M; Black D; Molgat Y; Bergeron D; de Launoit Y; Boudreau F; Desnoyers S; Guérin S
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6219-31. PubMed ID: 22915039
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
[TBL] [Abstract][Full Text] [Related]
25. Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation.
Shirai H; Fujimori H; Gunji A; Maeda D; Hirai T; Poetsch AR; Harada H; Yoshida T; Sasai K; Okayasu R; Masutani M
Biochem Biophys Res Commun; 2013 May; 435(1):100-6. PubMed ID: 23624507
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) degradation by post-nuclear extracts from human cells.
Rossi L; Denegri M; Torti M; Poirier GG; Ivana Scovassi A
Biochimie; 2002 Dec; 84(12):1229-35. PubMed ID: 12628300
[TBL] [Abstract][Full Text] [Related]
27. PARP and PARG inhibitors in cancer treatment.
Slade D
Genes Dev; 2020 Mar; 34(5-6):360-394. PubMed ID: 32029455
[TBL] [Abstract][Full Text] [Related]
28. Detecting and Quantifying pADPr In Vivo.
Lamade AM; Chen Y; Johnson CJ; Bayır H; Clark RSB
Methods Mol Biol; 2023; 2609():23-42. PubMed ID: 36515827
[TBL] [Abstract][Full Text] [Related]
29. Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice.
Cortes U; Tong WM; Coyle DL; Meyer-Ficca ML; Meyer RG; Petrilli V; Herceg Z; Jacobson EL; Jacobson MK; Wang ZQ
Mol Cell Biol; 2004 Aug; 24(16):7163-78. PubMed ID: 15282315
[TBL] [Abstract][Full Text] [Related]
30. DePARylation is critical for S phase progression and cell survival.
Nie L; Wang C; Huang M; Liu X; Feng X; Tang M; Li S; Hang Q; Teng H; Shen X; Ma L; Gan B; Chen J
Elife; 2024 Apr; 12():. PubMed ID: 38578205
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells.
Sasaki Y; Nakatsuka R; Inouchi T; Masutani M; Nozaki T
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563432
[TBL] [Abstract][Full Text] [Related]
32. Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death.
Kovács K; Erdélyi K; Hegedűs C; Lakatos P; Regdon Z; Bai P; Haskó G; Szabó E; Virág L
Free Radic Biol Med; 2012 Nov; 53(9):1680-8. PubMed ID: 22964577
[TBL] [Abstract][Full Text] [Related]
33. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry.
Isabelle M; Moreel X; Gagné JP; Rouleau M; Ethier C; Gagné P; Hendzel MJ; Poirier GG
Proteome Sci; 2010 Apr; 8():22. PubMed ID: 20388209
[TBL] [Abstract][Full Text] [Related]
34. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
35. Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer.
Martincuks A; Zhang C; Austria T; Li YJ; Huang R; Lugo Santiago N; Kohut A; Zhao Q; Borrero RM; Shen B; Cristea M; Wang EW; Song M; Rodriguez-Rodriguez L; Yu H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580335
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
Masutani M; Nakagama H; Sugimura T
Cell Mol Life Sci; 2005 Apr; 62(7-8):769-83. PubMed ID: 15868402
[TBL] [Abstract][Full Text] [Related]
37. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
[TBL] [Abstract][Full Text] [Related]
38. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
[TBL] [Abstract][Full Text] [Related]
39. Alteration of poly(ADP-ribose) glycohydrolase nucleocytoplasmic shuttling characteristics upon cleavage by apoptotic proteases.
Bonicalzi ME; Vodenicharov M; Coulombe M; Gagné JP; Poirier GG
Biol Cell; 2003 Dec; 95(9):635-44. PubMed ID: 14720466
[TBL] [Abstract][Full Text] [Related]
40. Analysis of ADP-ribose polymer sizes in intact cells.
Gagné JP; Shah RG; Poirier GG
Mol Cell Biochem; 2001 Aug; 224(1-2):183-5. PubMed ID: 11693195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
